68-4

18/136

1) Numasaki H, Nakada Y, Okuda Y, Ohba H, Teshima T, Ogawa K: Japanese structure survey of radiation oncology in 2015. J Radiat Res, 2022; 63: 230-246. 2) Naoi Y, Cho N, Miyauchi T, Iizuka Y, Maehara T, Katayama H: Usefulness and problems of stereotactic radiosurgery using a linear accelerator. Radiat Med, 1996; 14: 215-219. 3) Naoi Y, Maehara T, Cho N, Katayama H: Stereotactic radiosurgery for brain metastases using a linac system: evaluation of initial local response by imaging. Radiat Med, 1999; 17: 311-315. 4) Kitabatake T, Takahashi S: Conformation radiotherapy by means of a 6 MeV linear accelerator. Tohoku J Exp Med, 1968; 94: 37-43. 5) Takahashi S: Conformation radiotherapy. Rotation techniques as applied to radiography and radiotherapy 338of cancer. Acta Radiol Diagn (Stockh). 1965: Suppl 242: 1+. 6) Purdy JA: Advances in three-dimensional treatment planning and conformal dose delivery. Semin Oncol, 1997; 24: 655-671. 7) Zelefsky MJ, Leibel SA, Kutcher GJ, Fuks Z: Three-di‑mensional conformal radiotherapy and dose escalation: where do we stand? Semin Radiat Oncol, 1998; 8: 107-114. 8) Mackie TR, Kapatoes J, Ruchala K, et al: Image guid‑ance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys, 2003; 56: 89-105. 9) Harada T, Shirato H, Ogura S, et al: Real-time tumor-tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiber‑scopy. Cancer, 2002; 95: 1720-1727.10) Sritharan K, Tree A: MR-guided radiotherapy for pros‑tate cancer: state of the art and future perspectives. Br J Radiol, 2022; 95: 20210800.11) Ling CC, Humm J, Larson S, et al: Towards multidi‑mensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys, 2000; 47: 551-560.12) Okamoto S, Shiga T, Yasuda K, et al: The reoxygen‑ation of hypoxia and the reduction of glucose metabo‑lism in head and neck cancer by fractionated radio‑therapy with intensity-modulated radiation therapy. Eur J Nucl Med Mol Imaging, 2016; 43: 2147-2154.13) Tamaki N, Hirata K: Tumor hypoxia: a new PET imaging biomarker in clinical oncology. Int J Clin Oncol, 2016; 21: 619-625.14) Yoshida-Ichikawa Y, Horimoto Y, Shikama N, et al: Ipsilateral breast tumor control following hypofrac‑tionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow- up. Breast Cancer, 2021; 28: 92-98.15) Akamatsu M, Matsumoto T, Oka K, et al: c-erbB-2 oncoprotein expression related to chemoradioresis‑tance in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 2003; 57: 1323-1327.16) Kunogi H, Sakanishi T, Sueyoshi N, Sasai K: Prediction of radiosensitivity using phosphorylation of histone H2AX and apoptosis in human tumor cell lines. Int J Radiat Biol, 2014; 90: 587-593.17) Obinata M, Yamada K, Sasai K: Unusual olfactory perception during radiation sessions for primary brain tumors: a retrospective study. J Radiat Res, 2019; 60: 812-817.18) Hara N, Isobe A, Yamada K, et al: Unusual visual and olfactory perceptions during radiotherapy sessions: an investigation of the organs responsible. J Radiat Res, 2021; 62: 718-725.19) Kosugi Y, Hara N, Isobe A, Matsumoto F, Sasai K: Detection of ionising radiation by the CNS: a case report. Lancet Neurol, 2022; 21: 311-312.ConclusionsRadiation therapy has evolved from very primi‑tive techniques to a highly sophisticated and precise level during the past 40 years, along with advances and developments in instrumentation and techniques. It is crucial to stay up to date with these developments to maintain high-quality treat‑ment. The department of radiation oncology is currently small but has gradually expanded year by year. It is my hope that many young investiga‑tors will join this field in the future. AcknowledgmentsThe author thanks all members of the Department of Radiation Oncology, Juntendo University Graduate School of Medicine, for their many activities.No funding was received.Author contributionsKS contributed to the conception, drafting the manuscript, and preparation of figures and tables.Conflicts of interest statementThe Author declares that there are no conflicts of interest.ReferencesFunding